miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met (Q38845681)

6 September 2017

title

miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met (English)

1 reference

6 September 2017

1 reference

Fengming Lan

1

1 reference

6 September 2017

Huiming Yu

2

1 reference

6 September 2017

Man Hu

3

1 reference

6 September 2017

Tingyi Xia

4

1 reference

6 September 2017

Xiao Yue

5

1 reference

6 September 2017

language of work or name

English

0 references

publication date

6 August 2015

1 reference

Journal of Neurochemistry

6 September 2017

published in

1 reference

6 September 2017

volume

135

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

274-286

1 reference

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Diversifying microRNA sequence and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MET-mediated resistance to EGFR inhibitors: an old liaison rooted in colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Targeting MET: why, where and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MET: a critical player in tumorigenesis and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Determination of a novel anticancer c-Met inhibitor LS-177 in rat plasma and tissues with a validated UPLC-MS/MS method: application to pharmacokinetics and tissue distribution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases γ-radiation-induced sensitivity in some pancreatic cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Glioblastoma and other malignant gliomas: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Cell biology: Short RNAs and shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Targeting the c-Met/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Molecular neuro-oncology in clinical practice: a new horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13272

21 January 2018

Identifiers

DOI

10.1111/JNC.13272

1 reference

6 September 2017

1 reference